Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...

BlueArc Biosciences has been a winner in all three phases so far of the LymeX Innovation Accelerator competition as it works ...

Luna Bioscience moves ahead with work on a vaccine to prevent a deadly infection that spreads from animals to humans, as ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

Twist Bioscience Corporation (NASDAQ:TWST), a player in the U.S. Life Science Tools & Diagnostics sector, has been making ...

LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX) FDA feedback validates the clinical ...

Canada’s bio-economy is being reshaped by the forward-thinking organizations recognized today as 2024-2025 I.D.E.A.L.

Research analysts at William Blair issued their Q2 2026 earnings per share (EPS) estimates for Twist Bioscience in a report ...

Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines ...

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of ...

Skye Bioscience, Inc.’s SKYE share price has surged by 27.04%, which has investors questioning if this is right time to sell.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Skye Bioscience (SKYE – Research Report), Eton ...